Prevalence, predictors, and characteristics of off-treatment fatigue in breast cancer survivors.
Prevalence, predictors, and characteristics of off-treatment fatigue in breast cancer survivors.
复制标题
DOI:
10.1002/cncr.25294
复制
发表时间:
2010-12-15
期刊:
影响因子:
6.2
通讯作者:
Jacobsen, Paul B.
中科院分区:
文献类型:
--
作者:
Andrykowski, Michael A.;Donovan, Kristine A.;Laronga, Christine;Jacobsen, Paul B.
Lack of consensus regarding how to identify cancer patients with significant fatigue has hampered research regarding cancer-related fatigue (CRF). Specific criteria were used to identify CRF cases in women with stage 0-II breast cancer (BC group, n = 304). Women completed assessments before adjuvant therapy (baseline), end of adjuvant therapy (Post-Tx), and 6 and 42 months after end of adjuvant therapy (6 and 42 Month Post-Tx). At each, women completed a clinical interview and questionnaires assessing physical and mental health. A healthy control (HC) group with no history of BC (n = 337) completed 2 similar assessments 36 months apart. Off-treatment CRF prevalence was 9% and 13% at the 6 and 42 Month Post-Tx assessments, respectively. Thus, 15% of the sample evidenced off-treatment CRF with 7% evidencing delayed onset CRF. CRF at the 6 Month Post-Tx assessment was associated only with CRF at baseline (OR = 3.2) and Post-Tx assessments (OR = 3.9). CRF at the 42 Month Post-Tx assessment was associated with CRF at the Post-Tx assessment (OR = 6.1), obesity at baseline, and several baseline measures of coping in response to fatigue. Off-treatment CRF cases differed markedly from CRF noncases and healthy controls on a spectrum of health status indices (mean effect size >1.0 SD). Results document the prevalence of off-treatment and delayed onset CRF, suggest the utility of a cognitive-behavioral model of CRF, and support NCCN guidelines recommending monitoring fatigue across the cancer trajectory.
登录
查看更多内容
影响因子:
4.2
作者:
Donovan, Kristine A.;Small, Brent J.;Jacobsen, Paul B.
通讯作者:
Jacobsen, Paul B.
影响因子:
6.2
作者:
Jacobsen, Paul B.;Donovan, Kristine A.;Andrykowski, Michael A.
通讯作者:
Andrykowski, Michael A.
影响因子:
45.3
作者:
Andrykowski, MA;Schmidt, JE;Jacobsen, PB
通讯作者:
Jacobsen, PB
DOI:
10.1046/j.1523-5394.2001.009003119.x
发表时间:
2001-05-01
期刊:
CANCER PRACTICE
影响因子:
--
作者:
Mock, V;Pickett, M;McCorkle, R
通讯作者:
McCorkle, R
影响因子:
1.2
作者:
RADLOFF L S
通讯作者:
RADLOFF L S